工商銀行(01398.HK):馮衞東及陳怡芳離任非執行董事
格隆匯5月30日丨工商銀行(01398.HK)發佈公吿,本行非執行董事馮衞東因年齡原因,於2025年5月 30日向本行董事會提交辭呈,辭去本行非執行董事職務,同時不再擔任董事會審計委員會、風險管理委員會、提名委員會和美國區域機構風險委員會委員職務。
本行非執行董事陳怡芳因任期屆滿,自2025年5月30日起不再擔任本行非執行董事職務,同時不再擔任董事會戰略委員會、社會責任與消費者權益保護委員會和薪酬委員會委員職務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.